VU661013
VU661013 is a novel, potent, selective MCL1 inhibitor with Ki of 97 ± 30 pM of human MCL-1 in a TR-FRET assay. However, VU661013 does not significantly inhibit BCL-xL or BCL-2 with Ki > 40 μM or = 0.73 μM. VU661013 de-stabilizes BIM/MCL-1 association, leads to apoptosis in AML.
Supplier | Selleck Chemicals |
---|---|
Product # | S8758 |
Sku # | S8758-25mg |
Pricing | 25mg, $1770.00 |